ENVB vs. RAAX
ENVB (Enveric Biosciences Inc) is a stock, while RAAX (VanEck Inflation Allocation ETF) is Diversified Portfolio fund actively managed by VanEck. Over the past 5 years, ENVB returned -85.20%/yr vs 12.91%/yr for RAAX. At a 0.18 correlation, their price movements are largely independent.
Performance
ENVB vs. RAAX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ENVB achieves a -62.81% return, which is significantly lower than RAAX's 13.77% return.
ENVB
- 1D
- 1.50%
- 1M
- -38.91%
- YTD
- -62.81%
- 6M
- -71.09%
- 1Y
- -91.00%
- 3Y*
- -87.42%
- 5Y*
- -85.20%
- 10Y*
- -75.09%
RAAX
- 1D
- -1.27%
- 1M
- -4.59%
- YTD
- 13.77%
- 6M
- 11.58%
- 1Y
- 28.77%
- 3Y*
- 20.58%
- 5Y*
- 12.91%
- 10Y*
- —
ENVB vs. RAAX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | -62.81% | -94.37% | -72.43% | -37.50% | -95.53% | -37.16% | -34.51% | -48.17% | -88.05% |
RAAX VanEck Inflation Allocation ETF | 13.77% | 26.74% | 12.50% | 6.71% | 1.51% | 21.56% | -8.27% | 6.14% | -2.41% |
Correlation
The correlation between ENVB and RAAX is 0.22, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.22 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.15 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.21 |
Correlation (All Time) Calculated using the full available price history since Apr 10, 2018 | 0.18 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ENVB vs. RAAX — Risk / Return Rank
ENVB
RAAX
ENVB vs. RAAX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Enveric Biosciences Inc (ENVB) and VanEck Inflation Allocation ETF (RAAX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ENVB | RAAX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.54 | ||
| Sortino ratioReturn per unit of downside risk | -3.81 | ||
| Omega ratioGain probability vs. loss probability | 0.86 | 1.37 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.98 | 4.03 | -5.02 |
| Martin ratioReturn relative to average drawdown | -1.34 | 13.32 | -14.66 |
Loading charts...
Drawdowns
ENVB vs. RAAX - Drawdown Comparison
The maximum ENVB drawdown since its inception was -100.00%, which is greater than RAAX's maximum drawdown of -33.91%. Use the drawdown chart below to compare losses from any high point for ENVB and RAAX.
Loading charts...
Drawdown Indicators
| ENVB | RAAX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -100.00% | -33.91% | -66.09% |
Max Drawdown (1Y)Largest decline over 1 year | -92.64% | -7.17% | -85.47% |
Max Drawdown (3Y)Largest decline over 3 years | -99.81% | -11.59% | -88.22% |
Max Drawdown (5Y)Largest decline over 5 years | -100.00% | -23.55% | -76.45% |
Max Drawdown (10Y)Largest decline over 10 years | -100.00% | — | — |
Current DrawdownCurrent decline from peak | -100.00% | -6.93% | -93.07% |
Average DrawdownAverage peak-to-trough decline | -86.10% | -6.77% | -79.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 67.99% | 2.17% | +65.82% |
Volatility
ENVB vs. RAAX - Volatility Comparison
Enveric Biosciences Inc (ENVB) has a higher volatility of 21.90% compared to VanEck Inflation Allocation ETF (RAAX) at 4.82%. This indicates that ENVB's price experiences larger fluctuations and is considered to be riskier than RAAX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ENVB | RAAX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.90% | 4.82% | +17.08% |
Volatility (6M)Calculated over the trailing 6-month period | 105.52% | 12.36% | +93.16% |
Volatility (1Y)Calculated over the trailing 1-year period | 174.84% | 14.32% | +160.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 156.05% | 15.67% | +140.38% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 164.54% | 15.78% | +148.76% |
Dividends
ENVB vs. RAAX - Dividend Comparison
ENVB has not paid dividends to shareholders, while RAAX's dividend yield for the trailing twelve months is around 2.05%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
ENVB Enveric Biosciences Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
RAAX VanEck Inflation Allocation ETF | 2.05% | 2.34% | 1.91% | 3.66% | 1.53% | 8.72% | 6.27% | 2.37% | 0.56% |
Frequently Asked Questions
ENVB and RAAX have a correlation of 0.22, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ENVB has higher volatility (21.90%) compared to RAAX (4.82%). In terms of maximum drawdown, ENVB dropped -100.00% vs RAAX's -33.91%.
RAAX currently has the higher Sharpe Ratio (2.02 vs -0.52), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ENVB and RAAX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer